ConductScience.org, home

Paper14711

Characteristics of the cyclic nucleotide phosphodiesterases of normal and leukemic lymphocytes.

Hait WN and 1 other. Biochim Biophys Acta, 1977. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. Characteristics of the cyclic nucleotide phosphodiesterases of normal and leukemic lymphocytes. Papers, record 14711. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14711

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characteristics of the cyclic nucleotide phosphodiesterases of normal and leukemic lymphocytes.
PubMed
Journal
Biochim Biophys Acta
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
1.26
iCite
Revised in PubMed
2019-06-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hait WNW N
2Weiss BB

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
3',5'-Cyclic-AMP PhosphodiesterasesMajor topic
Leukemia, ExperimentalMajor topic
LymphocytesMajor topic
Phosphoric Diester HydrolasesMajor topic
Animals
Cell Line
Cyclic GMP
Drug Stability
Enzyme Activation
Female
Hydrogen-Ion Concentration
Lymphoid Tissue
Mice
Species Specificity
Subcellular Fractions

Source PubMed

Download CSV of topics

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
9566588Novel protein inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase from glioblastoma multiforme.Neurochem Res1998https://conductscience.org/library/papers/9566588PubMed
3995682Inhibition of growth of leukemic cells by inhibitors of calmodulin: phenothiazines and melittin.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/3995682PubMed
2820385Identification and characterization of a Ca2+-calmodulin-sensitive cyclic nucleotide phosphodiesterase in a human lymphoblastoid cell line.Biochem J1987https://conductscience.org/library/papers/2820385PubMed
228966Specific inhibition of a calcium dependent activation of brain cyclic AMP phosphodiesterase activity by vinblastine.Experientia1979https://conductscience.org/library/papers/228966PubMed
221534Adenylate cyclase in thymus-derived and bone marrow-derived lymphocytes from normal donors and patients with chronic lymphocytic leukemia.J Clin Invest1979https://conductscience.org/library/papers/221534PubMed
211511Calcitonin and calcium ionophores: cyclic AMP responses in cells of a human lymphoid line.Proc Natl Acad Sci U S A1978https://conductscience.org/library/papers/211511PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14711

GET https://conductscience.org/api/papers/v1/14711/authors